 |
|
|
| |
Switching from cART to dolutegravir monotherapy in virologically suppressed HIV-1 infected patients: A randomized clinical trial (DOMONO) - poster
|
| |
| |
Oral [more detailed] - Switching from combination antiretroviral therapy to DOlutegravir MONOtherapy in virologically suppressed HIV-1 infected adults: A randomized multicenter, non-inferiority clinical trial (DOMONO)
Reported by Jules Levin
HIV Glasgow 2016 Oct 23-26
E. A. Wijting1, C. Rokx1, C. A. B. Boucher2, J. J. A. van Kampen2, T. E. M. S. De Vries-Sluijs1, C. A. M. Schurink1, H. I. Bax1, M. A. Derksen1, E. R. Andrinopoulou3, M. E. Van der Ende1, E. C. M. Van Gorp1, J. L. Nouwen1, A. Verbon1, W. F. W. Bierman4, B. J. A. Rijnders1
1 Department of Internal Medicine and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands. 2 Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands. 3 Department of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands. 4 Universitary Medical Center Groningen, Groningen, The Netherlands.
|
| |
|
|
|
|
|
